23.4 C
New York
Thursday, June 11, 2026

Tag: rule

Lincoln Educational Services Reports Second Quarter Results and Increases Outlook for Full Year 2025

Conference Call Today at 10:00 a.m. Eastern Daylight Time
Conference Call Today at 10:00 a.m. Eastern Daylight Time

Helius Minerals Provides Update on Progress with the Serra Pelada Gold-PGM Project, Brazil

VANCOUVER, BC, Aug. 11, 2025 /CNW/ - Helius Minerals Limited ("Helius" or the "Company") (TSXV: HHH) is pleased to announce that after signing the...

DUPONT DE NEMOURS, INC. AND QNITY ELECTRONICS, INC. ANNOUNCE OFFERING OF SENIOR SECURED NOTES AND SENIOR NOTES

Notes to be the obligation solely of Qnity Electronics, Inc. as issuer following consummation of DuPont's intended Spin-Off of its electronics business WILMINGTON, Del., Aug....

BNPL Loans for Concert Tickets—Consider a Strategic Savings Approach Instead

The increasing popularity of buy now, pay later (BNPL) loans among different demographics presents financial implications for consumer spending, particularly for discretionary expenses such...

Pomerantz Law Firm Announces the Filing of a Class Action Against CTO Realty Growth, Inc. and Certain Officers – CTO

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CTO Realty Growth, Inc. (“CTO” or the “Company”) (NYSE: CTO) and certain officers.   The class action, filed in the United States District Court for the Middle District of Florida, and docketed under 25-cv-01516, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired CTO securities between February 18, 2021 and June 24, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Savoy Foundation’s 19th Annual Savoy Lecture Series

NEW YORK, Aug. 8, 2025 /PRNewswire/ -- The American Foundation of Savoy Orders, Inc. (Savoy Foundation) will host its 19th annual Lecture Series on...

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 10,200 shares of its common stock to fourteen newly-hired employees, with a grant date of August 5, 2025 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.

eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

AUSTIN, Texas, Aug. 8, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH) (ehealth.com), a leading private online health insurance marketplace (the "Company"), today announced that on...

Faraday Future Announces the Upcoming Special Meeting to Enable Rapid Execution of the Second Chapter of the Bridge Strategy and Adhere to Prudent Issuance...

Faraday Future Announces the Upcoming Special Meeting to Enable Rapid Execution of the Second Chapter of the Bridge Strategy and Adhere to Prudent Issuance

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

PetSmart Prices Notes Offering

PHOENIX, Aug. 8, 2025 /PRNewswire/ -- PetSmart LLC ("PetSmart") announced today that, together with its wholly-owned subsidiary, PetSmart Finance Corp. (the "Co-Issuer" and, together...

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on August 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 99,000 shares of Class A common stock and restricted stock units (RSUs) underlying 48,200 shares of Class A common stock to eight (8) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

Amwell makes grant to new employees under inducement plan

Amwell makes grant to new employees under inducement plan

- A word from our sponsors -

spot_img
HomeTagsRule